Andrew Joseph covers health, medicine, and the biopharma industest in Europe. You can reach Andrew on Signal at drewqjoseph.71. ROME…
Read More
FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder
Founders building in the healthcare space can’t just build rapid and break things. Timelines stretch longer, stakes are higher, and…
Read More
Syntara Limited Extfinishs Trading Halt Following Favourable FDA Review and Planned Capital Raising
Syntara Limited (ASX: SNT) has announced a continuation of its trading halt, originally initiated on 27 April 2026. The initial…
Read More
FDA Approval Efforts, Strategic Alternatives, and Financial Overview – Minichart
Key Points and Developments Business Focus: UHP develops, manufactures, and markets CelluSTAT®, a patented hemostatic gauze product for controlling bleeding…
Read More
FDA grants breakthrough device designation to ReVision Implant visual cortex prosthesis
Belgian neurotechnology startup ReVision Implant has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its…
Read More
OncoRes Medical Closes A$27 Million Private Round To Advance Elora QME Imaging System And U.S. FDA Pathway
OncoRes Medical has closed an AUD $27 million private funding round to advance clinical development and regulatory milestones for its…
Read More
Mounjaro pediatric EU nod, FDA orforglipron quick-track scrutiny, and what to watch next
Eli Lilly and Company shares concludeed Friday, Dec. 12, 2025 higher — and held roughly steady in after-hours trading —…
Read More
Arexvy EU Expansion, Blujepa FDA Approval, Analyst Forecasts and What’s Next
Published: 12 December 2025 GSK plc stock is back in focus on Friday as investors digest a quick-relocating cluster of…
Read More
Gene Therapy Breakthrough, FDA Setback, and What’s Next for QURE Stock
Company & Focus: UniQure N.V. is a Dutch-American biotechnology company (NASDAQ: QURE) specializing in gene therapies. It developed the first…
Read More
Mesoblast CEO Silviu Itescu reflects on FDA setbacks and commercial success of Ryoncil
Oct 18, 2025 – 5.00am Gift this article Subscribe to gift this article Gift 5 articles to anyone you choose…
Read More
